As the world battles the COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2, biopharma and biotech companies are approaching the fight with various weapons – repurposed drugs, antivirals, vaccines and clinical antibodies. One of the companies deeply involved in clinical antibody development against COVID-19 is San Diego-based Sorrento Therapeutics.
Shares of Abbott Laboratories dipped in trading following reports of a new study showing that the company’s approved COVID-19 testing kits have fallen short in accurately detecting the novel coronavirus.
Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.
Thermo Fisher Scientific Inc. expanded the company’s response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.
Rutgers’ RUCDR Infinite Biologics received an amended Emergency Use Authorization from the U.S. Food and Drug Administration for the first SARS-CoV-2 coronavirus test that will allow people to collect their own saliva at home and send to a lab for results.
Abbott Laboratories’ antibody test for the new coronavirus is highly likely to correctly determine whether people have ever been infected with the fast-spreading virus, the company said, citing a U.S. study.
The U.S. Food and Drug Administration said the regulatory agency would require antibody tests for the new coronavirus to undergo an agency review, reversing an earlier policy that had allowed fraudulent products to be marketed.
The U.S. Food and Drug Administration green-lit Roche’s new Elecsys Anti-SARS-CoV-2 antibody test that will help determine whether or not people have been infected by the novel coronavirus that has swept across the globe and developed antibodies to the disease.
United Nations leaders called for a global effort to develop and distribute to all at affordable prices vaccines, treatments and testing kits against COVID-19.
Roche won emergency approval from the U.S. Food and Drug Administration in for an antibody test to determine whether people have ever been infected with the coronavirus.
